$33.30
-0.24-0.72%
Last update: Nov 10, 8:50 AM
Cogent Biosciences Inc
COGTNASDAQ
The average analyst price target for Cogent Biosciences is $37.73, 13.3% above the current price. Of 12 analysts, 9 rate it Buy and 3 Hold. Targets range from $9 to $67. The latest change came on Nov 9, 2026, when HC Wainwright & Co. raised its price target on Cogent Biosciences from $55 to $56 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
